GGH
TO CONFIRM
Research compound; possibly the tripeptide Gly-Gly-His, a copper(II)-binding motif studied as a metal chelator, with identity to be confirmed.
Evidence level. Little or no public data, or the exact identity is still being confirmed. About the badges
- Class
- TO CONFIRM
- Category
- Antioxidants & Specialty
- Type
- Single compound
- Development and regulatory status
- Status not confirmed
What researchers study
The abbreviation GGH commonly denotes the tripeptide Gly-Gly-His, a copper(II)-binding motif studied as a metal chelator in laboratory work. Whether the catalogue item is this tripeptide is to be confirmed by Novatide.
Research areas
- Copper(II) chelation in peptide-binding studies
- Copper-mediated redox-reaction assays
- Amyloid-beta-copper toxicity models in cells
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- cell culture
Studies of Gly-Gly-His (if that is the intended compound) report selective chelation of Cu(II) from amyloid-beta-copper complexes in vitro
- cell culture
In PC-12 cell experiments, GGH increased cell viability from 36% to 63%
